Medistim ASA (FRA:MD1)

Market Cap	357.35M +54.2%
Revenue (ttm)	56.51M +22.2%
Net Income	12.15M +40.1%
EPS	0.66 +40.3%
Shares Out	n/a
PE Ratio	29.40
Forward PE	25.13
Dividend	0.51 (2.38%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	83
Open	19.95
Previous Close	19.55
Day's Range	19.50 - 19.95
52-Week Range	12.55 - 24.40
Beta	n/a
RSI	37.86
Earnings Date	Feb 27, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MD1

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK